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Abstract
Data on the burden of visceral leishmaniasis (VL) in Indian sub-continent are vital for elimination
programme planners for estimating resource requirements, effective implementation and monitoring
of elimination programme. In Indian sub-continent, about 200 million population is at risk of VL.
Nearly 25,000–40,000 cases and 200–300 deaths are reported every year, but these are grossly under-
estimates. Recent well-designed multicentric studies identified VL burden of 21 cases/10,000 among
sampled population in Indian sub-continent (Bangladesh, India and Nepal). This estimates 4,20,000
cases per 200 million risk population clearly indicating that the disease is highly under-reported.
Chemical and environmental vector control studies show that the indoor residual spraying (IRS) and
long-lasting insecticidal nets (LLINs) are effective and significantly reduce sandfly densities. The find-
ings documented from different sources revealed that some gaps and weakness in existing policies
for introducing VL vector control interventions. Our studies emphasize the need of integrated vector
management with both IRS and LLIN vector control interventions.  Active case detection with rK39
strip test as diagnostic tool is the key element for detection of VL cases. The use of oral drug miltefosine
for the treatment after assessing feasibility at community level is important. Kala-azar elimination in
Indian sub-continent is possible if elimination programmes ensure access to health care and preven-
tion of kala-azar for people at risk with particular attention to the poorest and marginalized groups.
The evidence-based policy should be designed that motivates to implement the programmes, which
will be cost-effective. Maintaining the acceptable level of incidence requires public awareness, vec-
tor control, appropriate diagnosis and treatment. The five pillars of VL elimination strategies identi-
fied are: early diagnosis and complete treatment; integrated vector management and vector surveil-
lance; effective disease surveillance through passive and active case detection; social mobilization and
building partnerships; and clinical and operational research which need to be re-enforced to effective
implementation.
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Introduction
Visceral leishmaniasis (VL) or kala-azar is a re-
emerging serious public health problem in the Indian
sub-continent targeting the poor. VL predominantly
affects the rural economy characterized by low hu-
man development and poverty; VL has become a
priority for the health and economic sectors in order
to achieve sustained economic growth through health
labour force and reduction of expenditure for disease.
In view of the increasing political commitment to VL
elimination and better funding opportunities, here
presented reviews are based on the recently con-
ducted TDR/WHO collaborative studies and avail-
able visceral leishmaniasis information from member
countries. The attempts have been made to estimateJ  VECTOR  BORNE  DIS  45, JUNE 2008 106
the annual incidence of the disease; describe the so-
cial and economic aspects of the disease; and vector
control strategies and effectiveness of different inter-
vention programmes.
VL has developed epidemic cycles taking place al-
most regularly every 15–20 years1. About 200 million
population is at risk of VL. Nearly 25,000–40,000
cases and 200–300 deaths are reported every year, but
these are possibly gross under estimates and there is
a need to determine the true burden of the disease2.
These official figures are likely to under estimate
grossly the real prevalence3. The disease has been re-
ported from 109 districts (45 in Bangladesh, 52 in
India and 12 in Nepal) of three countries (Fig. 1 &
Table 1).  There is an increasing trend of VL cases in
India and fluctuating trends were found in Nepal and
Bangladesh (Fig. 2). The Bihar state only has cap-
tured almost 50% cases out of total cases in Indian
sub-continent (Fig. 3). Due to this situation and be-
ing a border or near to border area of neighbour coun-
tries, Bihar seems as a source of VL. There might be
at least two reasons: (i) possibility of weak data
record system;  and (ii) intervention activities deter-
mined by past cases4.  There is also a report about the
occurrence of the disease in Bhutan (S. Bhattacharya,
Personal communication).
Estimation of visceral leishmaniasis (VL) burden
Multicentric studies were conducted in Bangladesh,
India and Nepal on the determination of the burden
of disease, health care seeking behaviour, behaviour
and knowledge of care providers in the formal and in-
formal sector and policy applications both in public
and private sectors5. The VL cases estimation was
made for Bangladesh, India and Nepal and it shows
that annual total number of VL cases occurred from
Bangladesh, India and Nepal  are 136,500, 270,900
and 12,600 respectively. The allocated budget per
head per year for risk population by national
programme was calculated and it was around US$
0.2, 0.4 and 0.3 for Bangladesh, India and Nepal re-
spectively (Table 2).
Major findings were that the current burden of dis-
ease (21 cases/10,000 population) is 20 times higher
than the elimination target in 2010/2015, treatment
delay is high (symptoms to diagnosis > 3 weeks 20%;
diagnosis to treatment > 3 weeks 31%), community
Fig. 1:VL endemic areas in Bangladesh, India and Nepal
(1995–2000)
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Table 1. Risk population, burden of disease and visceral leishmaniasis budget allocation
Countries Population Annual Estimated cases Annual Budget allocated
at risk VL cases based on budget allocated per head for risk
in million WHO/TDR study in million population (US$
21/10,000 population US$  per  person/year)
Bangladesh 65 5,067 136,500 14 0.2
India 129 33,613 270,900 50 0.4
Nepal 6 1,341 12,600 2 0.3
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Fig. 2: Burden of kala-azar in Indian sub-continent
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knowledge about VL and precaution is acceptable in
India and Nepal, but less so in Bangladesh. The rK39
test is used by 45–58% of care providers in India and
Nepal, but not yet in Bangladesh; knowledge among
care providers on drugs other than antimony,
miltefosine in particular, is good in India and Nepal,
but unsatisfactory in Bangladesh. Policies, compared
in Bihar and West Bengal, were found to be deficient
and not available for the private sector. A blueprint
plan for a focussed intervention in VL “hot spots”
identified by GIS mapping was presented. Based on
the current identified burden of the disease 21 cases/
10,000 among sampled population in Indian sub-con-
tinent (Bangladesh, India and Nepal), about  420,000
cases per 200 million risk population could be esti-
mated. This clearly indicates that the disease is highly
under-reported.
Economic impacts
The occurrence of the VL disease pushes the people
further into poverty from which they are not able to
come out of. VL leads to a loss of about 400,000
DALYs (Disability adjusted life years) every year in
this region6. This amounts to a loss of approximately
US$ 140 million annually (calculated at a loss of
about US$ 350 per DALY lost which is average
yearly income in the endemic countries of the region).
Table 2. Test of intervention effect for the pre-post control group design
Model Parameter p-value
LLIN IRS EVM
Simple Intervention effect 0.042 0 0.024
Full Intervention effect 0.044 0.001 0.025
Type of wall 0.881 0.260 0.925
Type of dwelling 0.996 0.032 0.020
Type of dwelling Intervention effect 0.042 0 0.024
Type of dwelling 0.970 0.043 0.021
Type of wall Intervention effect 0.044 0 0.025
Type of wall 0.876 0.289 0.875
LLIN— Long-lasting insecticidal net; IRS–—Indoor residual spray; EVM— Environmental
vector management.
Fig. 3: VL cases  in Bihar and other endemic areas
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VL not only worsens the poverty amongst the people,
it contributes to poor development of the area and
stresses the overstretched health system. The major
problems for producing desired outcomes were:
(i) lack of VL specific control and national progra-
mmes; (ii) no collaboration or interface with the pov-
erty focussed programmes; (iii) programmes were
based on the supply side rather than the demand side;
(iv) programmes were not based on public goods per-
spective; and (v) lack of coordination among the en-
demic countries to implement curative and preven-
tive VL control programmes. Allocation of resources
for controlling VL by the government from different
sources is another important aspect of cost analysis.
Allocation strategies are most important to gain the
allocative efficiency. It is revealed that  there was a
very small amount in allocation of government re-
sources for VL control among the countries. There
may be at least two reasons: (i) allocated amount has
captured  only preventive services because it is diffi-
cult to estimate shared cost of VL in the government
hospitals where other treatment and diagnosis services
are also available; and (ii) the government has been
paying less attention to control VL because govern-
ment assumes that VL is less productive area for in-
vestment and resources have diverted to other areas.
Social impacts
VL affects the rural poor, causing significant morbid-
ity and mortality. High cost of diagnosis and treat-
ment causes substantial social and economic hardship
for affected families. The burden of leishmaniasis is
disproportionate on the poorest segments of the popu-
lation. In endemic areas, increased infection risk is
mediated through poor housing conditions and envi-
ronmental sanitation, lack of personal protection
measures and economically driven migration and em-
ployment that bring people into contact with infected
sandflies. Poverty is associated with poor nutrition
and other infectious diseases, which increase the risk
that a person (once infected) will progress to the clini-
cally manifested disease. Lack of health care access
causes delay in appropriate diagnosis and treatment
and eventually increases leishmaniasis morbidity and
mortality. Leishmaniasis diagnosis and treatment are
expensive and families must sell assets and take loans
to pay for care, leading to further impoverishment
and reinforcement of the vicious cycle of disease and
poverty1,7. Visceral leishmaniasis has a huge social
impact due to lost educational potential, reduced
economic productivity, and stigma.  VL results in
missed days of work for adults, especially the family
breadwinner. Therefore, VL not only occurs in the
context of poverty, but through their adverse social
impact they may also promote poverty.  The stig-
matizing nature of VL often causes afflicted individu-
als to turn away from social contact.  The interruption
of public health services and forced human migra-
tions has produced resurgences in VL.
Vector control studies and strategies
The recent TDR supported multicentric study on
chemical and environmental vector control as a con-
tribution to the elimination of VL on the Indian sub-
continent shows that the IRS and to a lesser extent
environmental vector management (EVM) as well as
LLINs significantly reduced sandfly densities for at
least five to six months in study households indepen-
dent of type of walls and if people shared their house
with cattle or not. IRS was effective in all sites but
LLINs only in Bangladesh and India. Mud plastering
did not reduce sandfly densities (Bangladesh study);
lime plastering in India and one Nepali site resulted
in a significant reduction of sandfly densities but not
in the second Nepali site.
In Varanasi, India in 2007, Regional Technical Ad-
visory Committee (RTAC) for VL elimination to-
gether with the research teams concluded that chemi-
cal sandfly control with IRS can contribute to the
regional VL elimination programme and should be
continued and strengthened  in India and Nepal; and
operational research about performance and real life
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Bangladesh where vector control has largely been
abandoned during the last decade, the insecticide
treatment of existing bednets (coverage above 90%
in VL endemic districts) could bring an immediate
reduction of vector populations but should also be
accompanied by operational research for detecting
the most cost-effective strategy. Four different mod-
els were tested, simple not controlling for any
covariates, full model controlling for type of wall and
type of dwelling and the two semi-controlled models
(Table 2).
Management plan of the disease
In 2005, the three countries agreed to initiate a VL
elimination programme with high level political com-
mitment and the target of reducing annual VL inci-
dence to 1/10,000 population by 20158,9. Visceral
leishmaniasis elimination in this region is possible
because of its unique epidemiological features.
Favouring factors are: human beings the only reser-
voir host; Phlebotomus argentipes the only vector in
the region; VL focalized in 109 districts in three
countries; the disease easy to diagnose even in field
settings through recently developed rK39 dipstick
test and can be treated completely with effective
drugs. The five pillars of the VL elimination strategy
identified so far are:  (i) providing access to early
diagnosis and treatment; (ii) strengthening disease
and vector surveillance; (iii) integrated vector man-
agement; (iv) social mobilization and networking;
and (v) operational research.
Regional strategies, challenges and issues
The regional elimination programme is trying to en-
sure access to health care and prevention of kala-azar
for people at risk with particular attention to the poor-
est and marginalized groups. The strategies in imple-
mentation are focusing on: effective disease surveil-
lance through active and passive case detection
(PCD); early diagnosis by dipstick and complete
treatment; effective vector control through integrated
vector management with a focus on indoor residual
spray, insecticide-treated nets and environmental
management; social mobilization of the population at
risk and partnership; and clinical and operational
research to support the elimination programme10.
As the programme improves and capacity  increases,
PCD should be supplemented with active case detec-
tion (ACD) that is supported by laboratory diagnosis.
While ACD is recommended at least once a year in
the beginning (if possible two times per year), it will
become more important as the number of cases re-
ported by PCD declines. ACD should also be supple-
mented by laboratory confirmation of suspected
cases [Operational research is ongoing in
Bangladesh, India and Nepal to assess the cost effec-
tiveness of action (through contact tracing) and
PCD]. Partnerships will be necessary at all levels, i.e.
at district and state levels, at national level and with
international stakeholders. Partnerships networking
and collaboration will be required with other
programmes like vector-borne disease programmes
(malaria, dengue and filaria) and others, e.g. HIV/
AIDS, TB, and leprosy. Anaemia control, improve-
ment in nutritional status and poverty alleviation
programmes should be made partners of kala-azar
elimination programme. Operational research is rec-
ommended to establish monitoring of drug resistance,
drug-efficacy and quality of drugs used in the
programme. Research is also needed in searching for
cases of  post-kala-azar dermal leishmaniasis (PKDL)
and for satisfactory treatment of cases of PKDL. An
important operational research issue is to evaluate the
public-private mix. Networking is an important strat-
egy to optimize operational research and link it with
programme implementation.
Several constraints have still to be overcome: limited
sound data about VL incidence in the region; little
information about peoples’ access and use of diag-
nostic and treatment services in the public and private
sectors; speculation about their non-adherence pat-
tern to treatment-based on a suspected lack of knowl-J  VECTOR  BORNE  DIS  45, JUNE 2008 110
edge about the disease. Even though the political
commitment is high, the resource allocation until
recently has been low in Bangladesh and Nepal,
implementation has been inadequate, and the capac-
ity of the health system insufficient. However, this
information is of vital importance for designing appro-
priate and locally adapted VL elimination strategies.
Conclusion
Summary of information on the VL in Indian sub-
continent is shown in Table 3.  The estimated num-
ber of VL cases based on multicentric epidemiologi-
cal studies and institution-based reporting data from
the Indian sub-continent (Bangladesh, India and
Table 3. Summary information of visceral leishmanias (VL) in Indian sub-continent
Characteristics Bangladesh India Nepal
Endemic districts 45 52 districts of four states 12
Population at risk 65 129 6
   (in million)
Reported cases each 5067 33,613 1341
   year (cases in 2006)
Annual deaths 2006 22 175 12
Drugs for treatment Sodium antimony gluconate Miltefosine Sodium antimony gluconate,
amphotericin B, miltefosine
Diagnosis Direct agglutination test Syndromic approach rK39 test and parasitological test
and rK39 test and use of rK39 for
confirmation
Target year for 2015 2010 2015
  elimination
Vector control Indoor residual spraying Use of DDT spraying, Indoor residual spraying
entomological monitoring,
sanitation and personal
protection, together with
indoor spraying for
three consecutive years
Constraints  facilities for early diagnosis  under reporting  under reporting,
and prompt treatment  increasing PKDL cases  not enough information
are generally inadequate·  indiscriminate use of about PKDL cases
 during the past several years drugs, especially by  indiscriminate use of
Bangladesh has not done private doctors and drugs, especially by
IRS either for malaria control quacks private doctors and quacks
 or visceral leishmaniasis  sodium antimony  poor allocation of resources
elimination programme  gluconate resistance
 standard operating
procedures have been
developed, but
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Nepal) suggest to revise the earlier estimations on the
VL burden. Rural-urban and male-female prevalence
differentials must be kept in mind. The countries
refine their estimates as much as possible when more
surveillance and research data available. Recent mul-
ticentric research study on chemical and environmen-
tal vector control as a contribution of VL on the In-
dian sub-continent shows that the IRS and LLIN sig-
nificantly reduced sandfly densities.
The evidence-based policy should be designed that
motivate to implement and the programmes will be
cost-effective. Policies to control VL will have to in-
clude many activities that involve public awareness
and modifying personal behaviour. The cost and ef-
fectiveness of public information campaigns and
various programmes should have been studied in a
number of contexts in VL elimination. The five pil-
lars of VL elimination strategies identified are: early
diagnosis and complete treatment; integrated vector
management and vector surveillance; effective dis-
ease surveillance through passive and active case
detection; social mobilization and building partner-
ships; and clinical and operational research which
need to be re-enforced to effective implementation.
Dynamic models of epidemiology should have been
integrated with economic policy models for VL
elimination. Elimination of VL is not eradication,
which implies that the incidence of disease should be
maintained at acceptable minimum level.  Maintain-
ing the acceptable level of incidence requires that
resources be devoted to the programmes, and that the
programmes should be cost-effective.
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